BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1544594)

  • 1. Ectopic production of prolactin in uterine cervical carcinoma.
    Hsu CT; Yu MH; Lee CY; Jong HL; Yeh MY
    Gynecol Oncol; 1992 Feb; 44(2):166-71. PubMed ID: 1544594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding and growth-stimulation of cervical cancer cell lines by prolactin.
    Chen KW; Tsai YL; Chen WS; Lien YR; Su WH; Lee CY; Hsieh CY
    J Formos Med Assoc; 1992 Aug; 91(8):804-7. PubMed ID: 1362121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of association between hyperprolactinemia and colon carcinoma.
    Carlson HE; Zarrabi MH; Lyubsky SL
    Cancer Invest; 2000; 18(2):130-4. PubMed ID: 10705875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-associated antigen, TA-4, in the monitoring of the effects of therapy for squamous cell carcinoma of the uterine cervix. Serial determinations and tissue localization.
    Maruo T; Shibata K; Kimura A; Hoshina M; Mochizuki M
    Cancer; 1985 Jul; 56(2):302-8. PubMed ID: 2408732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RU486 suppresses prolactin production in explant cultures of leiomyoma and myometrium.
    Stewart EA; Austin DJ; Jain P; Penglase MD; Nowak RA
    Fertil Steril; 1996 Jun; 65(6):1119-24. PubMed ID: 8641483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of carcinoembryonic antigen in uterine cervical neoplasia.
    Agarwal S; Sharma S
    Indian J Med Res; 1990 Dec; 92():452-5. PubMed ID: 2079363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinoembryonic antigen in carcinoma of the uterine cervix: antigen distribution in primary and metastatic tumors.
    van Nagell JR; Hudson S; Gay EC; Donaldson ES; Hanson M; Powell DF; Goldenberg DM
    Cancer; 1982 Jan; 49(2):379-83. PubMed ID: 6274508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor markers CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen in patients with adenocarcinoma of the uterine cervix.
    Duk JM; Aalders JG; Fleuren GJ; Krans M; De Bruijn HW
    Obstet Gynecol; 1989 Apr; 73(4):661-8. PubMed ID: 2648225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ectopic production of prolactin by colorectal adenocarcinoma.
    Bhatavdekar JM; Patel DD; Chikhlikar PR; Shah NG; Vora HH; Ghosh N; Trivedi TI
    Dis Colon Rectum; 2001 Jan; 44(1):119-27. PubMed ID: 11805572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenoid basal carcinoma of the uterine cervix: immunohistochemical study and literature review.
    Senzaki H; Osaki T; Uemura Y; Kiyozuka Y; Ogura E; Okamura A; Tsubura A
    Jpn J Clin Oncol; 1997 Dec; 27(6):437-41. PubMed ID: 9438010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of ectopic production of human chorionic gonadotropin and human chorionic somatotropin by carcinoma of the uterine cervix.
    Das S; Mukherjee K; Bhattacharya S; Chowdhury JR
    Oncology; 1984; 41(5):303-7. PubMed ID: 6472766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Interplay Between Prolactin and Reproductive System: Focus on Uterine Pathophysiology.
    Auriemma RS; Del Vecchio G; Scairati R; Pirchio R; Liccardi A; Verde N; de Angelis C; Menafra D; Pivonello C; Conforti A; Alviggi C; Pivonello R; Colao A
    Front Endocrinol (Lausanne); 2020; 11():594370. PubMed ID: 33162942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum carcinoembryonic antigens in patients with carcinoma of the cervix.
    Ito H; Kurihara S; Nishimura C
    Obstet Gynecol; 1978 Apr; 51(4):468-71. PubMed ID: 566405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Papillary serous carcinoma of the uterine cervix: a clinicopathologic study of 17 cases.
    Zhou C; Gilks CB; Hayes M; Clement PB
    Am J Surg Pathol; 1998 Jan; 22(1):113-20. PubMed ID: 9422324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 60 kDa prolactin variant secreted by cervical cancer cells modulates apoptosis and cytokine production.
    Ramírez De Arellano A; Riera Leal A; Lopez-Pulido EI; González-Lucano LR; Macías Barragan J; Del Toro Arreola S; García-Chagollan M; Palafox-Sánchez CA; Muñoz-Valle JF; Pereira-Suárez AL
    Oncol Rep; 2018 Mar; 39(3):1253-1260. PubMed ID: 29399697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolactin and colorectal cancer: is there a connection?
    Baert D; Matthys C; Gillardin JP; Lepoutre L; Thienpont L; Kaufman JM; Cuvelier C; De Vos M
    Acta Gastroenterol Belg; 1998; 61(4):407-9. PubMed ID: 9923090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of pretreatment squamous cell carcinoma antigen and carcinoembryonic antigen in squamous cell carcinoma of the uterine cervix.
    Bae SN; Namkoong SE; Jung JK; Kim CJ; Park JS; Kim JW; Lee JM; Kim SJ
    Gynecol Oncol; 1997 Mar; 64(3):418-24. PubMed ID: 9062143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperprolactinemia and immunohistochemical expression of intracellular prolactin and prolactin receptor in primary central nervous system tumors and their relationship with cellular replication.
    Soares Leães CG; Filho AP; Pereira Lima JF; Dallago CM; Batista RL; Barbosa-Coutinho LM; Ferreira NP; da Costa Oliveira M
    Brain Tumor Pathol; 2007; 24(2):41-6. PubMed ID: 18095129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of prolactin receptors in normal and malignant uterine cervix.
    Dowsett M; McGarrick GE; Staffurth J; Worth RW; Chapman MG; Jeffcoate SL
    Br J Obstet Gynaecol; 1984 Sep; 91(9):924-6. PubMed ID: 6089861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenoma malignum (minimal deviation adenocarcinoma) of the uterine cervix. A clinicopathological and immunohistochemical analysis of 26 cases.
    Gilks CB; Young RH; Aguirre P; DeLellis RA; Scully RE
    Am J Surg Pathol; 1989 Sep; 13(9):717-29. PubMed ID: 2764221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.